Reducing Treatment-Related Morbidity and Mortality in Early-Stage Hodgkin’s Disease and Why the Recent Southwest Oncology Group Trial Is Not the Way to Go-Reference-Cited by-同舟云学术

Reducing Treatment-Related Morbidity and Mortality in Early-Stage Hodgkin’s Disease and Why the Recent Southwest Oncology Group Trial Is Not the Way to Go

Published:2002-05-01 Issue:9 Volume:20 Page:2225-2228
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Prosnitz Leonard R.¹

Affiliation:

1. Duke University Medical Center, Durham, NC

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2002.20.9.2225

Reference40 articles.

1. Gospodarowicz MK, Sutcliffe SB, Bergsagel DE, et al: Radiation therapy in clinical stage I and II Hodgkin’s disease: The Princess Margaret Hospital Lymphoma Group. Eur J Cancer 28A: 1841,1992-1846,

2. Hoppe RT: Radiation therapy in the management of Hodgkin’s disease. Semin Oncol 17: 704,1990-715,

3. Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation.

4. The Role of Radiation in the Management of Hodgkin's Disease: An Update

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignant Lymphomas and Lymphadenopathies;Oncology of Infancy and Childhood;2009

2. Two Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Extended-Field Radiotherapy Is Superior to Radiotherapy Alone in Early Favorable Hodgkin's Lymphoma: Final Results of the GHSG HD7 Trial;Journal of Clinical Oncology;2007-08-10

3. Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation;Blood;2004-11-01

4. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma;International Journal of Radiation Oncology*Biology*Physics;2004-07

5. Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study Group;Journal of Clinical Oncology;2003-10-01